Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Johnson & Johnson files patent infringement complaint against Penederm

Aug. 9, 1996

Kaken submits NDA for Fiblast in Japan

Aug. 9, 1996

Isotretinoin effective against acne

Aug. 9, 1996

SBI Skin Biology issued U.S. patent for Folligen and similar technology

July 26, 1996

Pimilprost shows wound healing properties in preclinical studies

July 26, 1996

Human Genome Sciences claims VIGF polypeptide technology

July 26, 1996

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

Chugai describes 24-oxo-22-oxavitamin D3 derivatives

July 26, 1996

FDA approval granted for Candela's ALEXlazr

July 19, 1996

Vanguard Medica exercises worldwide rights to VML-262

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...